A novel nanobiotherapeutic poly-[hemoglobin-superoxide dismutase-catalase-carbonic anhydrase] with no cardiac toxicity for the resuscitation of a rat model with 90 minutes of sustained severe hemorrhagic shock with loss of 2/3 blood volume

References

• Alayash AI. 2004. Oxygen therapeutics: can we tame Hb. Nat Rev Drug Discov. 3:152–159.
   PubMed Web of Science ®Google Scholar
• Bian Y, Rong Z, Chang TMS. 2011. PolyHb-superoxide dismutase-catalase-carbonic anhydrase: a novel biotechnology-based blood substitute that transports both oxygen and carbon dioxide and also acts as an antioxidant. Artif Cells Blood Substit Biotechnol. 39:127–136.
   PubMed Web of Science ®Google Scholar
• Bian YZ, Wei G, Chang TMS. 2013. Lowering of elevated tissue PCO2 in a hemorrhagic shock rat model after reinfusion of a novel nanobiotechnological PolyHb-superoxide dismutase-catalase- carbonic anhydrase that is an oxygen and carbon dioxide carrier with enhanced antioxidant properties. Artif Cells Nanomed Biotechnol. 41:60–68.
   PubMed Web of Science ®Google Scholar
• Biro GP, Ou C, Ryan-MacFarlane C, Anderson PJ. 1995. Oxyradical generation after resuscitation of hemorrhagic shock with blood or stromafree Hb. Artif Cells Blood Substit Immobiliz Biotechnol. 23:631–645.
   PubMed Web of Science ®Google Scholar
• Burhop KE, Estep TE. 2001. Hb induced myocardial lesions. Artif Cells Blood Substit Immobil Biotechnol. 29:101–106.
   Google Scholar
• Chang EJ, Lee TH, Mun KC, Kim HC, Suh SI, Bae JH, et al. 2004. Effects of polyHb-antioxidant enzyme complex on ischemia-reperfusion in kidney. Transplant Proc. 36:1952–1954.
   PubMed Web of Science ®Google Scholar
• Chang TMS (Ed.). 2013. Selected Topics in Nanomedicine. Singapore, London: World Science Publisher/Imperial College Press, 590 pages.
   Google Scholar
• Chang TMS. 1964. Semipermeable microcapsules. Science. 146: 524–525.
   PubMed Web of Science ®Google Scholar
• Chang TMS. 1971. Stabilisation of enzymes by microencapsulation with a concentrated protein solution or by microencapsulation followed by cross-linking with glutaraldehyde. Biochem Biophys Res Commun. 44:1531–1536.
   PubMed Web of Science ®Google Scholar
• Chang TMS. 1997. Red Blood Cell Substitutes: Principles, Methods, Products and Clinical Trials, Vol. I (Monograph). Karger/Landes Systems, Basel, Switzerland (available for free online viewing at www.medicine.mcgill.ca/artcell).
   Google Scholar
• Chang TMS. 2005. Therapeutic applications of polymeric artificial cells. Nat Rev Drug Discov. 4:221–235.
   PubMed Web of Science ®Google Scholar
• Chang TMS. 2007. Monograph on “ARTIFICIAL CELLS: Biotechnology, Nanotechnology, Blood Substitutes, Regenerative Medicine, bioencapsulation, cell/stem cell therapy”. Singapore, London: World Scientific Publisher/Imperial College Press, 454 pages. (available for free online viewing/download at www.medicine.mcgill.ca/artcell).
   Google Scholar
• D’Agnillo F, Chang TMS. 1998. PolyHb-superoxide dismutasecatalase as a blood substitute with antioxidant properties. Nat Biotechnol. 16:667–671.
   PubMed Web of Science ®Google Scholar
• Geers C, Gros G. 2000. Carbon dioxide transport and carbonic anhydrase in blood and muscle. Physiol Rev. 80:681–715.
   PubMed Web of Science ®Google Scholar
• Gould, SA, Sehgal LR, Sehgal HL, GS Moss. 1995. The development of Hb solutions as red cell substitutes:Hb solutions. Transfu Sci. 16:5–17.
   PubMedGoogle Scholar
• Gu G, Chang TMS. 2009. Extraction of erythrocyte enzymes for the preparation of PolyHb-catalase-superoxide dismutase. Artif Cells Blood Substit Biotechnol. 37:69–77.
   PubMed Web of Science ®Google Scholar
• Hess JR, Johansson PI, Holcomb JB, et al. 2011. Massive transfusion and transfusion therapy in trauma In: Mintz PD, Ed. Transfusion Therapy: Clinical Principles and Practice. 3rd ed. Bethesda, Maryland: AABB Press, pp. 305–322.
   Google Scholar
• Jahr JS, Mackenzie C, Pearce LB, Pitman A, Greenburg AG. 2008. HBOC-201 as an alternative to blood transfusion: efficacy and safety evaluation in a multicenter phase III trial in elective orthopaedic surgery. J Trauma. 64:1484–1497.
   PubMed Web of Science ®Google Scholar
• Jia YP, Alayash AI. 2013. Molecular Basis of Haptoglobin and Hb Complex Formation and Protection against Oxidative Stress and Damage in “Selected Topics in Nanomedicine” Editor TMS Chang, World Science Publisher/Imperial College Press, Singapore London 149–168.
   Google Scholar
• Kim HW, Greenburg AG (Eds.). 2014. Hemoglobin-Based Oxygen Carriers as Red Cell Substitutes and Oxygen Therapeutics. New York, London: Springer, 738 pages
   Google Scholar
• Klein HG. 2000. The prospects for red-cell substitutes. N Engl J Med. 342:1666–1668.
   PubMed Web of Science ®Google Scholar
• Li T, Yu R, Zhang HH, Liang WG, Yang XM, Yang CM. 2006. A method for purification and viral inactivation of human placenta Hb. Artif Cells Blood Substit Biotechnol. 34:175–188.
   PubMed Web of Science ®Google Scholar
• Lui FE, Kluger R. 2011. Reviving artificial blood: meeting the challenge of NO scavenging by hemoglobin. Chem Biochem. 11:1816–1824.
   Google Scholar
• Ma L, Hsia CJC. 2013. Polynitroxylated Hb as a multifunctional therapeutic for critical care and transfusion medicine. In: Chang TMS (Ed.). Selected Topics in Nanomedicine. Singapore, London: World Science Publisher/Imperial College Press, pp. 169–194.
   Google Scholar
• Mazurier C, Douay L, Lapillonne H. 2011. RBC from induced pluripotent stem cells: hurdles and developments. Curr Opin Hematol. 18:249–253.
   PubMed Web of Science ®Google Scholar
• Moore E, Moore FA, Fabian TC, Bernard AC, Fulda GJ, Hoyt DB, et al. 2009. Human polymerized hemoglobin for the treatment of hemorrhagic shock when blood is unavailable: the USA multicenter trial. J Am Coll Surg. 208:1–13.
   PubMed Web of Science ®Google Scholar
• Nadithe V, Bae YH. 2011. Hb Conjugates with antioxidant enzymes(Hb-superoxide dismutase-catalase) via poly(ethylene glycol) crosslinker for protection of pancreatic beta RINm5F cells in hypoxia. Tissue Eng. 17:2453–2462.
   Google Scholar
• Natanson C, Kern SJ, Lurie P, Banks SM, Wolfe SM. 2008. Cell-free hemoglobin-based blood substitutes and risk of myocardial infarction and death: a meta-analysis. JAMA. 299:2304–2312.
   PubMed Web of Science ®Google Scholar
• Powanda D, Chang TMS. 2002. Cross-linked polyHb-superoxide dismutase-catalase supplies oxygen without causing blood brain barrier disruption or brain edema in a rat model of transient global brain ischemia-reperfusion. Artif Cells Blood Substit Immobiliz Biotechnol. 30:25–42.
   Google Scholar
• Sims C, Seigne P, Menconi M, Monarca J, Barlow C, Pettit J, Puyana JC. 2001. Skeletal muscle acidosis correlates with the severity of blood volume loss during shock and resuscitation. J Trauma. 51:1137–1146.
   PubMed Web of Science ®Google Scholar
• Tronstad C, Pischke SE, Holhjem L, Tonnessen TI, Martinsen OG, Grimnes S. 2010. Early detection of cardiac ischemia using a conductometric PCO 2 sensor: real-time drift correction and parameterization. Physiol Meas. 31:1241–1255.
   PubMed Web of Science ®Google Scholar
• Winslow RM (Ed.). 2006. Blood Substitutes. Amsterdam: Academic Press.
   Google Scholar
• Wong N, Chang TMS. 2007. PolyHb-fibrinogen: a novel blood substitutes with platelet-like activity for extreme hemodilution. Artif Cells Blood Substit Biotechnol. 35:481–489.
   PubMed Web of Science ®Google Scholar
• Yu B, Shahid M, Egorina EM, Sovershaev MA, Raher MJ, Lei C, et al. 2010. Endothelial dysfunction enhances vasoconstriction due to scavenging of nitric oxide by a hemoglobin-based oxygen carrier Anesthesiology. 112:586–594.
   PubMed Web of Science ®Google Scholar
• Zhu HL, Du QQ, Chen C, Chang TMS. 2010. The immunological properties of stroma-free polyhemolysate containing catalase and superoxide dismutase activities prepared by polymerized bovine stroma-free hemolysate. Artif Cells Blood Substit Biotechnol. 38:57–63.
   PubMed Web of Science ®Google Scholar